Danimer Scientific, Inc.

As of August 9, 2022, Danimer Scientific, Inc. is considered overvalued and risky due to poor financial ratios and a year-to-date return of -89.76%, significantly underperforming compared to its peers and the S&P 500.

As of April 11, 2025, Danimer Scientific, Inc. shows a mildly bearish trend, with daily moving averages indicating bearish signals, while weekly indicators suggest short-term strength, but overall caution is advised due to bearish tendencies in Bollinger Bands and OBV.

Danimer Scientific, Inc. is a micro-cap company in the specialty chemicals industry, reporting net sales of $9 million and a net loss of $22 million as of September 2024. The company has a market cap of $0.79 million and key metrics indicate it is currently loss-making with a debt-to-equity ratio of 1.75.

As of Jun 18, Danimer Scientific, Inc. has a market capitalization of 0.79 million, with net sales of 37.43 million and a net profit loss of 111.19 million over the last four quarters. Shareholder's funds total 278.02 million, and total assets are reported at 730.28 million.